Epigral Ltd Board Meeting on Nov 2, 2026 for Q2 FY27 Results

Epigral Limited has announced that its Board of Directors will convene on Monday, November 2, 2026. The primary agenda item for this meeting is the consideration and approval of the Un-Audited Financial Results for the Second Quarter and Half Year ended September 30, 2026. The results will be presented on both a standalone and consolidated basis. Additionally, the Board will review the Limited Review Report from the Statutory Auditors. The meeting will also address any other business as permitted by the Chair. This intimation is provided for the information of the company's shareholders.